Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT04735341
Official study title

Prospective Post-market Data Collection for Ion Endoluminal System to Understand CT to Body Divergence

Study summary

The goal of this study is to collect post-market data for the Ion Endoluminal System to understand CT to body divergence.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedIon Endoluminal System

The study team can explain what participation involves.

Who it may be forLung Cancer · Pulmonary Nodule, Solitary

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Aug 9, 2022 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Intuitive Surgical

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Intuitive Surgical
Interventions being studied
Device: Ion Endoluminal System
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Age of 18 years or older
  • Undergoing a lung biopsy procedure with Ion System
  • Have peripheral pulmonary lesion (5th bronchial generation or higher)
  • Willingness to participate as demonstrated by signing the informed consent
Reasons someone may not be able to joinExclusion criteria
  • Unable to provide informed consent
  • Presence of bilateral nodules intended to be biopsied during procedure
  • The presence of medical conditions contraindicating general anesthesia or bronchoscopic biopsy
  • Vulnerable population (e.g., prisoners, mentally disabled)

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • FirstHealth of the Carolinas Moore Regional HospitalPinehurst, North Carolina

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 9, 2022. Always confirm current availability with the study team.

View original record ↗